The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Tricida, Inc. (“Tricida” or the “Company”) (NASDAQ: TCDA) securities during the period from September 4, 2019 through October 28, 2020, inclusive
(the “Class Period”). Investors have until March 8, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
According to the Complaint, the Company made false and misleading statements to the market. Tricida’s NDA submission for veverimer was materially deficient as submitted to the FDA. The Company’s failure to produce a sufficient NDA for veverimer was likely to result in the FDA not accepting the application. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Tricida, investors suffered damages.
If you purchased or otherwise acquired Tricida securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at email@example.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.